{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:59:05Z","timestamp":1793501945521,"version":"4.5.0"},"reference-count":49,"publisher":"BMJ","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272956"],"award-info":[{"award-number":["82272956"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Prevention and Control of Emerging and Major Infectious Diseases-National Science and Technology Major Project","award":["2025ZD01906400-2025ZD01906401"],"award-info":[{"award-number":["2025ZD01906400-2025ZD01906401"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2026,8,30]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The gut microbiome has been linked to immune checkpoint inhibitor (ICI) outcomes, but the temporal dynamics of microbial communities during treatment remain poorly characterised.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To characterise gut microbiome trajectories during ICI therapy and evaluate whether on-treatment microbial states improve the identification and generalisability of pretreatment biomarker signatures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>We performed a large prospective longitudinal shotgun metagenomic study of 315 patients with advanced primary liver cancer receiving ICI-based therapy, profiling 777 serial stool metagenomes collected at baseline and at approximately 3-month intervals on treatment. Responders (durable clinical benefit \u22656 months) contributed extended follow-up beyond 18 months. On-treatment windows were used for feature discovery; baseline-trained models were evaluated across all nine public ICI cohorts (n=1204).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Responders showed higher baseline alpha diversity and distinct community structure. Longitudinal profiling revealed marked ecological remodelling during therapy in both response groups, characterised by reduced network connectivity, increased modularity and strong time point specificity of discriminatory species. Using the on-treatment contrast at ~6 months (T2) as a discovery window, we identified a 16-species panel. A baseline model built from this panel outperformed models based on baseline-only feature discovery and generalised across nine public ICI studies. The resulting gut microbiome-derived immunotherapy outcome score stratified overall and progression-free survival in the discovery cohort (HRs 0.49 and 0.44) and across multiple external datasets, including stable-disease subsets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The gut microbiome undergoes structured ecological remodelling during ICI therapy; on-treatment longitudinal windows improve pretreatment signature portability and support microbiome-guided stratification in immuno-oncology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/gutjnl-2026-339115","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:20:20Z","timestamp":1789579220000},"page":"gutjnl-2026-339115","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Longitudinal gut microbiome dynamics during immunotherapy identify microbial features of clinical benefit in advanced primary liver cancer"],"prefix":"10.1136","author":[{"given":"Zhenwei","family":"Qian","sequence":"first","affiliation":[{"name":"Peking University 302 Clinical Medical School, Peking University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Han","sequence":"additional","affiliation":[{"name":"Senior Department of Hepatology, Chinese PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beile","family":"Lyu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, Xiamen, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aizier","family":"Ainiwaer","sequence":"additional","affiliation":[{"name":"Peking University 302 Clinical Medical School, Peking University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiancheng","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Urology, First Hospital, Peking University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Wang","sequence":"additional","affiliation":[{"name":"Senior Department of Hepatology, Chinese PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Cheng","sequence":"additional","affiliation":[{"name":"Senior Department of Hepatology, Chinese PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinyin","family":"Li","sequence":"additional","affiliation":[{"name":"Senior Department of Hepatology, Chinese PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Sun","sequence":"additional","affiliation":[{"name":"Senior Department of Hepatology, Chinese PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiannian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurobiology, School of Basic Medical Sciences, Beijing Key Laboratory of Neural Regeneration and Repair, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7737-2334","authenticated-orcid":false,"given":"Yinying","family":"Lu","sequence":"additional","affiliation":[{"name":"Peking University 302 Clinical Medical School, Peking University, Beijing, China"},{"name":"Senior Department of Hepatology, Chinese PLA General Hospital, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"2026091610201234000_gutjnl-2026-339115v1.1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31840"},{"key":"2026091610201234000_gutjnl-2026-339115v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00252-7"},{"key":"2026091610201234000_gutjnl-2026-339115v1.3","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(25)00543-1"},{"key":"2026091610201234000_gutjnl-2026-339115v1.4","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad1329"},{"key":"2026091610201234000_gutjnl-2026-339115v1.5","doi-asserted-by":"publisher","DOI":"10.1126\/science.aac4255"},{"key":"2026091610201234000_gutjnl-2026-339115v1.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2017.08.004"},{"key":"2026091610201234000_gutjnl-2026-339115v1.7","doi-asserted-by":"publisher","DOI":"10.1126\/science.aao3290"},{"key":"2026091610201234000_gutjnl-2026-339115v1.8","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan4236"},{"key":"2026091610201234000_gutjnl-2026-339115v1.9","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan3706"},{"key":"2026091610201234000_gutjnl-2026-339115v1.10","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01695-5"},{"key":"2026091610201234000_gutjnl-2026-339115v1.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.05.029"},{"key":"2026091610201234000_gutjnl-2026-339115v1.12","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02823-z"},{"key":"2026091610201234000_gutjnl-2026-339115v1.13","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02803-3"},{"key":"2026091610201234000_gutjnl-2026-339115v1.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2024.10.006"},{"key":"2026091610201234000_gutjnl-2026-339115v1.15","doi-asserted-by":"publisher","DOI":"10.1038\/nature13568"},{"key":"2026091610201234000_gutjnl-2026-339115v1.16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41575-020-00376-3","article-title":"Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure","volume":"18","author":"Trebicka","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2026091610201234000_gutjnl-2026-339115v1.17","doi-asserted-by":"crossref","unstructured":"V\u00e1zquez-Castellanos JF , Yoon SJ , Won S-M , et al . Stage-dependent gut microbiome and functional signatures across the liver disease spectrum: an integrative multicohort study. Gut 2026:gutjnl-2025-337436. doi:10.1136\/gutjnl-2025-337436","DOI":"10.1136\/gutjnl-2025-337436"},{"key":"2026091610201234000_gutjnl-2026-339115v1.18","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jhep.2024.09.046","article-title":"Oral-gut microbiome interactions in advanced cirrhosis: characterisation of pathogenic enterotypes and salivatypes, virulence factors and antimicrobial resistance","volume":"82","author":"Lee","year":"2025","journal-title":"J Hepatol"},{"key":"2026091610201234000_gutjnl-2026-339115v1.19","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003334","article-title":"Gut microbiome is associated with the clinical response to anti-PD-1 based immunotherapy in hepatobiliary cancers","volume":"9","author":"Mao","year":"2021","journal-title":"J Immunother Cancer"},{"key":"2026091610201234000_gutjnl-2026-339115v1.20","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004779","article-title":"Gut microbiota and metabolites associate with outcomes of immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma","volume":"10","author":"Lee","year":"2022","journal-title":"J Immunother Cancer"},{"key":"2026091610201234000_gutjnl-2026-339115v1.21","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008686","article-title":"Characterizations of multi-kingdom gut microbiota in immune checkpoint inhibitor-treated hepatocellular carcinoma","volume":"12","author":"Zhu","year":"2024","journal-title":"J Immunother Cancer"},{"key":"2026091610201234000_gutjnl-2026-339115v1.22","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/HEP.0000000000001446","article-title":"Distinct gut microbiota but common metabolomic signatures between viral and MASLD HCC contribute to outcomes of combination immunotherapy","volume":"84","author":"Lee","year":"2026","journal-title":"Hepatology"},{"key":"2026091610201234000_gutjnl-2026-339115v1.23","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb5920"},{"key":"2026091610201234000_gutjnl-2026-339115v1.24","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf3363"},{"key":"2026091610201234000_gutjnl-2026-339115v1.25","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02453-x"},{"key":"2026091610201234000_gutjnl-2026-339115v1.26","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1038\/s41591-025-04186-5","article-title":"Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial","volume":"32","author":"Duttagupta","year":"2026","journal-title":"Nat Med"},{"key":"2026091610201234000_gutjnl-2026-339115v1.27","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/s41591-025-04189-2","article-title":"Fecal microbiota transplantation plus pembrolizumab and axitinib in metastatic renal cell carcinoma: the randomized phase 2 TACITO trial","volume":"32","author":"Porcari","year":"2026","journal-title":"Nat Med"},{"key":"2026091610201234000_gutjnl-2026-339115v1.28","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00152.2012"},{"key":"2026091610201234000_gutjnl-2026-339115v1.29","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24423"},{"key":"2026091610201234000_gutjnl-2026-339115v1.30","doi-asserted-by":"publisher","DOI":"10.1038\/S41591-021-01655-5"},{"key":"2026091610201234000_gutjnl-2026-339115v1.31","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad2602"},{"key":"2026091610201234000_gutjnl-2026-339115v1.32","doi-asserted-by":"publisher","DOI":"10.1126\/science.ady1729"},{"key":"2026091610201234000_gutjnl-2026-339115v1.33","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41579-025-01266-8","article-title":"Keystone concept revisited: insights into microbial community dynamics and control","volume":"24","author":"Garza","year":"2026","journal-title":"Nat Rev Microbiol"},{"key":"2026091610201234000_gutjnl-2026-339115v1.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.09.024"},{"key":"2026091610201234000_gutjnl-2026-339115v1.35","doi-asserted-by":"crossref","DOI":"10.1186\/s40425-019-0650-9","article-title":"Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma","volume":"7","author":"Zheng","year":"2019","journal-title":"J Immunother Cancer"},{"key":"2026091610201234000_gutjnl-2026-339115v1.36","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1158\/2159-8290.CD-21-0808","article-title":"A Natural Polyphenol Exerts Antitumor Activity and Circumvents Anti-PD-1 Resistance through Effects on the Gut Microbiota","volume":"12","author":"Messaoudene","year":"2022","journal-title":"Cancer Discov"},{"key":"2026091610201234000_gutjnl-2026-339115v1.37","doi-asserted-by":"crossref","DOI":"10.1093\/jambio\/lxad221","article-title":"Gut microbial signatures of patients with primary hepatocellular carcinoma and their healthy first-degree relatives","volume":"134","author":"Feng","year":"2023","journal-title":"J Appl Microbiol"},{"key":"2026091610201234000_gutjnl-2026-339115v1.38","doi-asserted-by":"crossref","unstructured":"Xu W , Jiang Y , Tao J , et al . Correlation analysis for alterations of intestinal flora in hepatocellular carcinoma patients: combinatorial detection of Coriobacterium, Atopobium, Coprococcus and Veillonella dispar may be a new method for HCC diagnosis. J Med Microbiol 2023;72. doi:10.1099\/jmm.0.001713","DOI":"10.1099\/jmm.0.001713"},{"key":"2026091610201234000_gutjnl-2026-339115v1.39","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-317836"},{"key":"2026091610201234000_gutjnl-2026-339115v1.40","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.chom.2025.04.022","article-title":"Microbiota-derived urocanic acid triggered by tyrosine kinase inhibitors potentiates cancer immunotherapy efficacy","volume":"33","author":"Zhang","year":"2025","journal-title":"Cell Host Microbe"},{"key":"2026091610201234000_gutjnl-2026-339115v1.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2020.04.044"},{"key":"2026091610201234000_gutjnl-2026-339115v1.42","doi-asserted-by":"crossref","unstructured":"Xu Y , Mo Y , Zhou W , et al . Sorafenib induces intestinal toxicity by disturbing gut microbiota and activating the LPS\/TLR4\/NF-\u03baB signaling pathway in mice. Toxicology 2025;517. doi:10.1016\/j.tox.2025.154220","DOI":"10.1016\/j.tox.2025.154220"},{"key":"2026091610201234000_gutjnl-2026-339115v1.43","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bty560"},{"key":"2026091610201234000_gutjnl-2026-339115v1.44","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.65088","article-title":"Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3","volume":"10","author":"Beghini","year":"2021","journal-title":"Elife"},{"key":"2026091610201234000_gutjnl-2026-339115v1.45","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-023-01688-w"},{"key":"2026091610201234000_gutjnl-2026-339115v1.46","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2011-12-6-r60","article-title":"Metagenomic biomarker discovery and explanation","volume":"12","author":"Segata","year":"2011","journal-title":"Genome Biol"},{"key":"2026091610201234000_gutjnl-2026-339115v1.47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004226","article-title":"Sparse and compositionally robust inference of microbial ecological networks","volume":"11","author":"Kurtz","year":"2015","journal-title":"PLoS Comput Biol"},{"key":"2026091610201234000_gutjnl-2026-339115v1.48","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s42256-019-0138-9","article-title":"From Local Explanations to Global Understanding with Explainable AI for Trees","volume":"2","author":"Lundberg","year":"2020","journal-title":"Nat Mach Intell"},{"key":"2026091610201234000_gutjnl-2026-339115v1.49","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01698-2"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2026-339115","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:20:24Z","timestamp":1789579224000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2026-339115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":49,"alternative-id":["10.1136\/gutjnl-2026-339115"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2026-339115","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]}}}